CN1223564C - 中间体卤代苯基衍生物及其在制备吡咯衍生物中的应用 - Google Patents

中间体卤代苯基衍生物及其在制备吡咯衍生物中的应用 Download PDF

Info

Publication number
CN1223564C
CN1223564C CNB028126416A CN02812641A CN1223564C CN 1223564 C CN1223564 C CN 1223564C CN B028126416 A CNB028126416 A CN B028126416A CN 02812641 A CN02812641 A CN 02812641A CN 1223564 C CN1223564 C CN 1223564C
Authority
CN
China
Prior art keywords
compound
converted
general formula
reaction
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028126416A
Other languages
English (en)
Chinese (zh)
Other versions
CN1520390A (zh
Inventor
M·绍库普
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of CN1520390A publication Critical patent/CN1520390A/zh
Application granted granted Critical
Publication of CN1223564C publication Critical patent/CN1223564C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483—Monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CNB028126416A 2001-06-26 2002-06-17 中间体卤代苯基衍生物及其在制备吡咯衍生物中的应用 Expired - Lifetime CN1223564C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01115355 2001-06-26
EP01115355.8 2001-06-26

Publications (2)

Publication Number Publication Date
CN1520390A CN1520390A (zh) 2004-08-11
CN1223564C true CN1223564C (zh) 2005-10-19

Family

ID=8177821

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028126416A Expired - Lifetime CN1223564C (zh) 2001-06-26 2002-06-17 中间体卤代苯基衍生物及其在制备吡咯衍生物中的应用

Country Status (17)

Country Link
US (1) US7115643B2 (cg-RX-API-DMAC7.html)
EP (1) EP1399402B1 (cg-RX-API-DMAC7.html)
JP (1) JP4125672B2 (cg-RX-API-DMAC7.html)
KR (1) KR100898887B1 (cg-RX-API-DMAC7.html)
CN (1) CN1223564C (cg-RX-API-DMAC7.html)
AT (1) ATE482920T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002321068B2 (cg-RX-API-DMAC7.html)
BR (1) BR0210701A (cg-RX-API-DMAC7.html)
CA (1) CA2449800C (cg-RX-API-DMAC7.html)
CY (1) CY1111510T1 (cg-RX-API-DMAC7.html)
DE (1) DE60237817D1 (cg-RX-API-DMAC7.html)
DK (1) DK1399402T3 (cg-RX-API-DMAC7.html)
ES (1) ES2349918T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA03010914A (cg-RX-API-DMAC7.html)
PT (1) PT1399402E (cg-RX-API-DMAC7.html)
WO (1) WO2003002498A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200309101B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207352B2 (en) * 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
KR102129150B1 (ko) * 2012-08-07 2020-07-02 바실리어 파마슈티카 아게 이사부코나졸 또는 라부코나졸의 제조 방법
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
CN105801500B (zh) * 2014-12-31 2018-08-24 四川科伦药物研究院有限公司 拆分艾沙康唑中间化合物消旋体的方法
CN115611822B (zh) * 2022-10-12 2023-09-19 四川澄华生物科技有限公司 艾沙康唑中间体的制备方法
CN116478103B (zh) * 2023-03-24 2025-07-25 四川澄华生物科技有限公司 一种拆分艾沙康唑中间体4的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395942A (en) 1980-06-02 1995-03-07 Zeneca Limited Heterocyclic compounds
DE3942790A1 (de) 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur herstellung von 2-(4-chlorphenyl)-3-methylbuttersaeure
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
ES2062941B1 (es) 1993-03-15 1995-10-01 Uriach & Cia Sa J Nuevos derivados de azol activos por via oral.
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions

Also Published As

Publication number Publication date
EP1399402B1 (en) 2010-09-29
PT1399402E (pt) 2010-11-30
AU2002321068B2 (en) 2007-11-15
DE60237817D1 (de) 2010-11-11
JP4125672B2 (ja) 2008-07-30
KR20040012982A (ko) 2004-02-11
BR0210701A (pt) 2004-07-20
EP1399402A1 (en) 2004-03-24
MXPA03010914A (es) 2004-02-17
ATE482920T1 (de) 2010-10-15
CA2449800A1 (en) 2003-01-09
WO2003002498A1 (en) 2003-01-09
US20040176432A1 (en) 2004-09-09
KR100898887B1 (ko) 2009-05-21
ZA200309101B (en) 2005-03-30
US7115643B2 (en) 2006-10-03
ES2349918T3 (es) 2011-01-13
CY1111510T1 (el) 2015-08-05
CN1520390A (zh) 2004-08-11
DK1399402T3 (da) 2010-11-15
CA2449800C (en) 2009-09-29
JP2004535444A (ja) 2004-11-25

Similar Documents

Publication Publication Date Title
WO2021074739A1 (en) An industrial scale process for the preparation of prothioconazole
WO2004000826A1 (ja) エポキシトリアゾール誘導体およびその中間体の製造方法
CN1520390A (zh) 中间体卤代苯基衍生物及其在制备吡咯衍生物中的应用
KR101574655B1 (ko) (1h-1,2,4-트리아졸-1-일)아릴 화합물 및 그 제조방법
AU2002321068A1 (en) Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
CN103608334B (zh) 咪唑衍生物的制备方法
CN103180305B (zh) 环氧基醇化合物的制造方法
EP2721014A2 (en) Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
WO2009024214A1 (en) Process for the production of voriconazole
JP2004535444A5 (cg-RX-API-DMAC7.html)
JP3407088B2 (ja) トリアゾール誘導体の製造方法およびその中間体
CN107311946A (zh) 2‑(1h‑1,2,3‑三氮唑基)‑3‑羟基联苯‑4‑羧酸乙酯类化合物的合成方法
CN101500992A (zh) 制备1-甲基碳青霉烯制备用中间体的方法
CN100503544C (zh) 用于制备环氧三唑衍生物的中间体
JPH04356471A (ja) トリアゾール化合物およびその用途
CN114213278B (zh) 一种苄重氮基苯乙酮类化合物的合成方法及苄重氮基苯乙酮类化合物
JP4173335B2 (ja) 光学活性2,3−エポキシプロパン誘導体の製造法
EP1475370A1 (en) Optically active azole derivative and process for producing the same
CN101665508A (zh) 4位-1H-1,2,3-三唑-β-内酰胺衍生物的制备方法
WO2006059759A1 (ja) エポキシトリアゾール誘導体の製造方法
JP4326816B2 (ja) 光学活性アゾール誘導体およびその製造法
JP4397579B2 (ja) 1−置換−4−カルバモイル−1,2,4−トリアゾール−5−オン誘導体の製造方法
JP2003327578A (ja) 光学活性2−フェニル−2,3−ジヒドロキシプロピルアゾール誘導体の製造法
JP2006182766A (ja) エポキシトリアゾール誘導体およびその中間体の製造方法
JPH08253452A (ja) 光学活性トリアゾール誘導体の製造法およびその中間体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20051019

CX01 Expiry of patent term